{
    "RET Rearrangement Positive": {
        "First-line Therapy": {
            "Selpercatinib": "Progression (See NSCL-27)",
            "Pralsetinib": "Progression (See NSCL-27)",
            "Cabozantinib": "Progression (See NSCL-27)"
        },
        "Progression": {
            "Immunotherapy +/- Chemotherapy": "Progression (See NSCL-27)"
        }
    },
    "footnotes": {
        "1": "See Principles of Systemic Therapy (NSCL-F)."
    }
}